Lyell Immunopharma, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Lyell Immunopharma, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2020 to Q3 2024.
  • Lyell Immunopharma, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $5.06M, a 14.4% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.06M +$638K +14.4% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.24M -$281K -6.22% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $4.24M -$364K -7.91% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $4.24M -$445K -9.51% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $4.42M +$1.51M +51.8% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $4.52M +$808K +21.8% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $4.6M +$1.03M +29% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $4.68M +$1.2M +34.4% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $2.91M +$245K +9.18% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $3.71M +$921K +33% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $3.57M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $3.48M +$714K +25.8% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $2.67M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $2.79M Jun 30, 2021 10-Q 2021-08-12
Q4 2020 $2.77M Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.